Jean-jacques Body - Publications

Bone strain index improves 10-year fracture risk prediction beyond bone mineral density and FRAX® in community-dwelling older women: A study of the FRISBEE cohort.

Journal: Bone

Published: December 05, 2025

A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.

Journal: Clinical and translational science

Published: September 22, 2025

Corrigendum to "The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab" [Clin Ther. 2024;46:916-926].

Journal: Clinical therapeutics

Published: August 15, 2025

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: May 06, 2025

Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG.

Journal: Journal of bone oncology

Published: April 09, 2025

Osteosarcopenia, sarcopenia, and their associations with validated recent fragility fractures in older women: applying seven definitions in the FRISBEE 2 study.

Journal: European geriatric medicine

Published: February 28, 2025

Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Journal: BMC cancer

Published: January 09, 2025

Bone Effects of Anti-Cancer Treatments in 2024.

Journal: Calcified tissue international

Published: December 30, 2024

Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: November 28, 2024

The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab.

Journal: Clinical therapeutics

Published: June 13, 2024

When and How to Evaluate Vitamin D Status? A Viewpoint from the Belgian Bone Club.

Journal: Nutrients

Published: June 10, 2024

Association between sarcopenia, its components, and osteoporosis in the FRISBEE cohort.

Journal: BMC musculoskeletal disorders

Published: March 25, 2024